| 物质名称 | CAS登记号 | 物质唯一标识 | 分子式 | 异名/同义词 |
|---|---|---|---|---|
| BELANTAMAB MAFODOTIN | 2050232-20-5 | DB1041CXDG | BELANTAMAB MAFODOTIN-BLMF BLENREP GSK2857916 GSK-2857916 IMMUNOGLOBULIN G1, ANTI-(TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF17),(HUMANIZED MONOCLONAL GSK2857914 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL GSK2857914 .KAPPA.-CHAIN, DIMER, TETRATHIOETHER WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-N-METHYL-L-VALYL-L-VALYL-(3R,4S,5S)-3-METHOXY-5-METHYL-4-(METHYLAMINO)HEPTANOYL-(.ALPHA.R,.BETA.R,2S)-.BETA.-METHOXY-.ALPHA.-METHYL-2-PYRROLIDINEPROPANOYL-L-PHENYLALANINE IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 17 (B-CELL MATURATION PROTEIN, ANTIGEN CD269))HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN F.GAMMA.1 HEAVY CHAIN (1-451) (HUMANIZED VH (HOMO SAPIENS IGHV1-69*06 (84%) (IGHD)-IGHJ4*01 (86%)) (8.8.14) (1-121)-HOMO SAPIENS IGHG1*01 (122-451)) (224-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-33*01 (91%) IGKJ2*02 (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (230-230'':233-233'')-BISDISULFIDECONJUGATED, ON AN AVERAGE OF 4 CYSTEINYL RESIDUES (C), TO MONOMETHYL AURISTATIN F VIA MALEIMIDOCAPROYL LINKER. BELANTAMAB MAFODOTIN BELANTAMAB MAFODOTIN [INN] BELANTAMAB MAFODOTIN [JAN] BELANTAMAB MAFODOTIN [MI] BELANTAMAB MAFODOTIN [USAN] BELANTAMAB MAFODOTIN [WHO-DD] BELANTAMAB MAFODOTIN BLMF [WHO-DD] |